Xiaofang Wen

Title: Innovations of Xiaofang Wen in Biological Research

Introduction

Xiaofang Wen is a notable inventor based in Zhejiang, China, recognized for his contributions to the field of biology. He holds 2 patents that focus on innovative solutions for medical applications, particularly in the treatment of diseases.

Latest Patents

Wen's latest patents include significant advancements in the development of heavy-chain antibodies (VHHs) against claudin 18A2. This patent details an anti-CLD18A2 VHH that can specifically bind to the epitope on CLD18A2, demonstrating good specificity and affinity, along with a noticeable tumor suppression effect. Another patent involves the creation of fusion proteins for treating intestinal diseases, which consist of a GLP-2 receptor agonist, a peptide linker, and a long-acting carrier protein. This fusion protein exhibits significant bioactivities and in vitro stability.

Career Highlights

Throughout his career, Xiaofang Wen has worked with Zhejiang Doer Biologics Co., Ltd. and Zhejiang Doer Biologics Corporation, where he has contributed to various innovative projects in biological research.

Collaborations

Wen has collaborated with notable coworkers, including Gaofeng Yao and Yanshan Huang, who have supported his research endeavors.

Conclusion

Xiaofang Wen's innovative work in the field of biology, particularly through his patents, showcases his commitment to advancing medical science and improving treatment options for various diseases.